Immunotherapy in gestational trophoblastic neoplasia: advances and future directions
Gestational trophoblastic neoplasia (GTN) is a rare but aggressive malignancy that follows normal or aberrant pregnancies. Until the advent of immunotherapy in 2017, surgery and chemotherapy were the standard treatment modalities, with chemotherapy remaining the cornerstone. However, chemoresistance...
Saved in:
| Main Authors: | Jing Zeng, Jing Zhang, Jianzhang Wang, Lian Xu, Cheng Wang, Rutie Yin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1544585/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of lung metastasis on the treatment and prognosis of patients with gestational trophoblastic neoplasia: A systematic review and meta‐analysis
by: Taohong Zhang, et al.
Published: (2024-04-01) -
Pemphigoid gestationis associated with gestational trophoblastic neoplasia: A case report
by: Jasmine H. Wong, et al.
Published: (2025-06-01) -
Management of “Ultra-High Risk” gestational trophoblastic neoplasia at a tertiary center in India
by: Shilpa M Patel, et al.
Published: (2020-01-01) -
Gestational trophoblastic neoplasia with cardiac metastasis and multiple embolic manifestations: A rare case report
by: Akila B, et al.
Published: (2025-07-01) -
Successful treatment of high-risk gestational trophoblastic disease in a patient with intolerance to standard chemotherapy (clinical case)
by: G. M. Teletaeva, et al.
Published: (2021-01-01)